ArticleBiological trace element research2026
Toxicological Assessment of Cobalt-Chromium Dental Alloys: Ion Release, Cytotoxicity, and Possible Systemic Effects.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative Cytotoxicity of Commercially Pure Titanium, Silver-Palladium and Nickel-Chromium Alloys on Human Gingival Fibroblasts: An In Vitro Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cobalt-chromium (Co-Cr) alloys have broad applications in dental practice because of their mechanical strength and durability. However, the corrosive oral environment promotes ion release, raising concerns about toxicity. This study assessed the cytotoxic, oxidative stress, and inflammatory effects of ions released from Co-Cr alloys. Co-Cr alloy specimens were subjected to a six-month immersion test in artificial saliva, followed by quantification of released ions via Inductively Coupled Plasma Mass Spectrometry. Cytotoxicity was assessed in human fibroblast cells, and systemic toxicity was evaluated in male mice (n = 20), divided into control and Co-Cr alloy released ions treated groups. Results revealed a progressive release of Co and Cr ions, peaking at three months. The cytotoxicity assay showed reduced fibroblast viability accompanied by a 2-fold upregulation of the pro-apoptotic marker (Bax) and tumor necrosis factor-alpha, along with a 5-fold increase in interleukin-6 expression. Furthermore, Co-Cr alloy released ions induced a significant increase in oxidative damage, as evidenced by elevated thiobarbituric acid reactive substances and DNA frequency breakage. Antioxidants defenses, including glutathione reductase, catalase, and reduced glutathione, were significantly suppressed in hepatic and renal tissues as compared to the control group. Serum biochemical markers revealed impaired hepatic and renal function, accompanied by dyslipidemia. Histopathological analysis confirmed inflammatory infiltration, hepatocellular degeneration, and tubular alterations. Overall, Co-Cr alloy released ions elicit cytotoxic, oxidative, and inflammatory responses at both cellular and systemic levels. These findings highlight the potential health risks of long-term Co-Cr restorations and emphasize the need for the development of safer alternative biomaterials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.